Australia markets closed

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (603896.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
38.00+0.57 (+1.52%)
At close: 03:00PM CST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
795,043
767,137
636,051
546,759
511,452
Cost of revenue
119,762
126,373
105,672
85,407
72,063
Gross profit
675,281
640,765
530,379
461,352
439,389
Operating expenses
Research development
53,661
50,825
48,485
39,419
33,667
Selling general and administrative
355,846
355,429
309,012
292,630
289,593
Total operating expenses
432,660
440,809
374,181
347,367
339,957
Operating income or loss
242,621
199,956
156,198
113,985
99,432
Interest expense
9,054
10,170
11,716
978.9927
969.1143
Income before tax
244,241
201,061
153,702
124,994
110,088
Income tax expense
455.9957
749.2865
1,990
1,099
2,435
Income from continuing operations
243,785
200,311
151,712
123,895
107,653
Net income
243,911
200,827
151,712
123,895
107,653
Net income available to common shareholders
243,911
200,827
151,712
123,895
107,653
Basic EPS
-
1.03
0.82
0.68
0.58
Diluted EPS
-
1.03
0.82
0.68
0.58
Basic average shares
-
194,832
184,323
183,027
184,143
Diluted average shares
-
194,832
184,323
183,027
184,143
EBITDA
-
265,128
208,753
167,012
149,862